← brief for 2026-10-02 · Slowing decline
GLP-1 Receptor Agonists and Risk of Kidney Replacement Therapy and Health Care Utilization in Bipolar Disorder With Chronic Kidney Disease
Key takeaways
This study looks at a diabetes drug and kidney outcomes. It focuses on people with bipolar disorder. It does not have an abstract to review. There are no specific results to report from this item.
Who did this work
Balwinder Singh · Maria Lourdes Gonzalez Suarez · Hossam M. Ali · Raman K. Baweja
Source
Article · OpenAlex, CKD works · 2026-10-01
https://doi.org/10.4088/jcp.26m16392